Report overview
A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.
This report aims to provide a comprehensive presentation of the global market for Infectious Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Vaccines. This report contains market size and forecasts of Infectious Vaccines in global, including the following market information:
Global Infectious Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Infectious Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Infectious Vaccines companies in 2022 (%)
The global Infectious Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.
We surveyed the Infectious Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Infectious Vaccines Market Segment Percentages, by Type, 2022 (%)
Preventive Vaccine
Therapeutic Vaccine
Global Infectious Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Infectious Vaccines Market Segment Percentages, by Application, 2022 (%)
Adults
Pediatrics
Global Infectious Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Infectious Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Infectious Vaccines revenues share in global market, 2022 (%)
Key companies Infectious Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Infectious Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc. (U.S.)
MedImmune LLC (U.S.)
Johnson and Johnson (U.S.)
Novartis AG (Switzerland)
Merck and Company (U.S.)
Sanofi Pasteur (France)
Pfizer Inc. (U.S.)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Infectious Vaccines, market overview.
Chapter 2: Global Infectious Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Infectious Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Infectious Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Infectious Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
